Tuberculosis Testing Market to reach US$2.6 bn by 2020 owing to Increasing Tuberculosis Awareness and Control Programs GloballyNewsletter PrintingUpdated on Dec 22, 2016 View more like this | Visit ALBANY, NY | Contact Transparency market research |
A new Transparency Market Research report states that the global tuberculosis testing market stood at US$1.9 bn in 2013 and is predicted to reach US$2.6 bn by 2020. It is predicted to expand at a CAGR of 4.30% from 2014 to 2020. The title of the report is “Tuberculosis Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.”
As per the report, the rising acceptance of numerous TB testing techniques owing to the increasing prevalence of diseases globally is propelling the market for tuberculosis testing. In addition, a number of tuberculosis awareness and control programs launched by various non-government and government organizations globally will also augment the market for tuberculosis testing. Furthermore, the great market potential exhibited by a number of developing economies globally will bring in new growth opportunities in the market. On the other hand, factors such as the soaring costs of numerous tuberculosis tests may impede the growth of the market in forthcoming years.
Download free exclusive Brochure of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2267
The report segments the market on the basis of test type and geography:
In terms of test type, the market is segmented into culture-based tests, smear microscopy, nucleic acid testing, radiography (chest x-ray), Mantoux test (tuberculin skin test), drug susceptibility testing (DST), and others including adenosine deaminase (ADA), serological tests, interferon-gamma release assays (IGRA), etc. Amongst these, the segment of culture-based tests led the market in 2014. Culture-based tuberculosis tests comprise both liquid and solid culture tests and they are broadly accepted owing to their relatively high accuracy and specialty as compared to other types of tuberculosis tests. On the other hand, the segment of other tests is predicted to exhibit the swiftest growth in the forecast horizon owing to their numerous advantages including high accuracy, rapid result generation, and single visit requirement, among others.
View exclusive Global strategic Business report:
http://www.transparencymarketresearch.com/tuberculosis-testing-market.html
In terms of geography, the report segments the market into Europe, Asia Pacific, North America, and Rest of the World (RoW). Amongst these, Asia Pacific held the largest share in the market in 2013 and was trailed by North America. The reason for the superiority of Asia Pacific is the increasing patient pool, raising the occurrence of numerous diseases within this region, particularly within China and India. On the other hand, North America has a comparatively smaller patient pool; however, the increasing awareness amongst people, proliferation of advanced tuberculosis tests, and the advanced healthcare infrastructure of this region makes it the second largest tuberculosis testing market globally.
According to the report, the prominent players operating in the market are Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche, Ltd., Hain Lifescience GmbH, bioMérieux SA, Hologic, Inc. QIAGEN, Akonni Biosystems, Inc., Abbott Laboratories, Alere, Inc., Cepheid, Epistem, Plc. and Sanofi, among others.
As per the report, the rising acceptance of numerous TB testing techniques owing to the increasing prevalence of diseases globally is propelling the market for tuberculosis testing. In addition, a number of tuberculosis awareness and control programs launched by various non-government and government organizations globally will also augment the market for tuberculosis testing. Furthermore, the great market potential exhibited by a number of developing economies globally will bring in new growth opportunities in the market. On the other hand, factors such as the soaring costs of numerous tuberculosis tests may impede the growth of the market in forthcoming years.
Download free exclusive Brochure of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2267
The report segments the market on the basis of test type and geography:
In terms of test type, the market is segmented into culture-based tests, smear microscopy, nucleic acid testing, radiography (chest x-ray), Mantoux test (tuberculin skin test), drug susceptibility testing (DST), and others including adenosine deaminase (ADA), serological tests, interferon-gamma release assays (IGRA), etc. Amongst these, the segment of culture-based tests led the market in 2014. Culture-based tuberculosis tests comprise both liquid and solid culture tests and they are broadly accepted owing to their relatively high accuracy and specialty as compared to other types of tuberculosis tests. On the other hand, the segment of other tests is predicted to exhibit the swiftest growth in the forecast horizon owing to their numerous advantages including high accuracy, rapid result generation, and single visit requirement, among others.
View exclusive Global strategic Business report:
http://www.transparencymarketresearch.com/tuberculosis-testing-market.html
In terms of geography, the report segments the market into Europe, Asia Pacific, North America, and Rest of the World (RoW). Amongst these, Asia Pacific held the largest share in the market in 2013 and was trailed by North America. The reason for the superiority of Asia Pacific is the increasing patient pool, raising the occurrence of numerous diseases within this region, particularly within China and India. On the other hand, North America has a comparatively smaller patient pool; however, the increasing awareness amongst people, proliferation of advanced tuberculosis tests, and the advanced healthcare infrastructure of this region makes it the second largest tuberculosis testing market globally.
According to the report, the prominent players operating in the market are Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche, Ltd., Hain Lifescience GmbH, bioMérieux SA, Hologic, Inc. QIAGEN, Akonni Biosystems, Inc., Abbott Laboratories, Alere, Inc., Cepheid, Epistem, Plc. and Sanofi, among others.
